文献速递肝病

晚期非酒精性脂肪肝病失代偿或发生于较低肝静脉压力梯度水平

Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-10-21

该多中心横断面研究纳入548例晚期非酒精性脂肪肝病(aNAFLD)和444例晚期丙型肝炎(aHCV)患者,比较肝静脉压力梯度(HVPG)与失代偿的关系。

要点

  • aNAFLD患者HVPG中位数低于aHCV患者(13 vs 15 mmHg)
  • 任何HVPG cutoff下aNAFLD失代偿患病率均高于aHCV

核心结论

  • 晚期NAFLD患者在任一HVPG水平下门脉高压相关失代偿的患病率均高于晚期HCV患者。

研究设计与样本

  • 多中心横断面研究,纳入548例晚期NAFLD和444例晚期丙型肝炎患者,均接受HVPG测量、胃镜和腹部影像学检查。

主要发现

  • aNAFLD组HVPG中位数低于aHCV组(13 vs 15 mmHg)。
  • 在HVPG cutoff <10、10-12或12 mmHg时,aNAFLD组失代偿患病率均高于aHCV组。

关键数值与推荐

  • HVPG cutoff分层:<10 mmHg、10-12 mmHg、12 mmHg。

临床怎么用

  • 临床评估aNAFLD患者门脉高压相关失代偿风险时,需注意其可能在较低HVPG水平即发生失代偿。

局限性

  • 横断面设计无法确定因果关系或预测阈值;需纵向研究确定aNAFLD人群的HVPG预测阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Portal hypertension is the strongest predictor of hepatic decompensation and death in patients with cirrhosis. However, its discriminatory accuracy in patients with nonalcoholic fatty liver disease (NAFLD) has been challenged because hepatic vein catheterization may not reflect the real portal vein pressure as accurately as in patients with other etiologies. We aimed to evaluate the relationship between hepatic venous pressure gradient (HVPG) and presence of portal hypertension-related decompensation in patients with advanced NAFLD (aNAFLD). METHODS: Multicenter cross-sectional study included 548 patients with aNAFLD and 444 with advanced RNA-positive hepatitis C (aHCV) who had detailed portal hypertension evaluation (HVPG measurement, gastroscopy, and abdominal imaging). We examined the relationship between etiology, HVPG, and decompensation by logistic regression models. We also compared the proportions of compensated/decompensated patients at different HVPG levels. RESULTS: Both cohorts, aNAFLD and aHVC, had similar baseline age, gender, Child-Pugh score, and Model for End-Stage Liver Disease score. Median HVPG was lower in the aNAFLD cohort (13 vs 15 mmHg) despite similar liver function and higher rates of decompensation in aNAFLD group (32% vs 25%; P = .019) than in the aHCV group. For any of the HVPG cutoff analyzed (<10, 10-12, or 12 mmHg) the prevalence of decompensation was higher in the aNAFLD group than in the aHCV group. CONCLUSIONS: Patients with aNAFLD have higher prevalence of portal hypertension-related decompensation at any value of HVPG as compared with aHCV patients. Longitudinal studies aiming to identify HVPG thresholds able to predict decompensation and long-term outcomes in aNAFLD population are strongly needed.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bassegoda O, Olivas P, Turco L, et al. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. Clin Gastroenterol Hepatol. 2021. PMID: 34688952. doi:10.1016/j.cgh.2021.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。